Jakub Czapiński

Jakub Czapiński

Auto-generated profile, based on publicly available information

Jakub Czapiński

A Department of Biochemistry and Molecular Biology , Medical University of Lublin , Lublin , Poland

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2018 in Expert Opinion on Drug Discovery
Verified
Journal Article
Closed access
Michał KiełbusMichał Kiełbus
Michał Kiełbus
JCJakub Czapiński
Jakub Czapiński
AOAdrian Odrzywolski
Adrian Odrzywolski
GSGrażyna Stasiak
Grażyna Stasiak
KSKamila Szymańska
Kamila Szymańska
Adolfo Rivero-MüllerAdolfo Rivero-Müller
Adolfo Rivero-Müller
The discovery and domestication of biomolecules that respond to light has taken a light of its own, providing new molecular tools with incredible spatio-temporal resolution to manipulate cellular behavior. Areas covered: The authors herein analyze the current optogenetic tools in light of their current, and potential, uses in cancer drug discovery, biosafety and cancer biology. Expert opinion: The pipeline from drug discovery to the clinic is plagued with drawbacks, where most drugs fail in either efficacy or safety. These issues require the redesign of the pipeline and the development of more controllable/personalized therapies. Light is, aside from inexpensive, almost harmless if used appropriately, can be directed to single cells or organs with controllable penetration, and comes in a variety of wavelengths. Light-responsive systems can activate, inhibit or compensate cell signaling pathways or specific cellular events, allowing the specific control of the genome and epigenome, and modulate cell fate and transformation. These synthetic molecular tools have the potential to revolutionize drug discovery and cancer research.